Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jon M Hanifin

Showing results (41-50 of 80) with videos related to

Pageof 8
Sort By:
The Journal of Allergy and Clinical Immunology|May 13, 2018
Nemolizumab in patients with moderate-to-severe atopic dermatitis: Randomized, phase II, long-term extension studyKenji Kabashima, Masutaka Furue, Jon M Hanifin, et al.
Dermatology Online Journal|September 7, 2004
Tacrolimus ointment: utilization patterns in children under age 2 yearsTamara Salam Housman, Amy B Norton, Steven R Feldman, et al.
Pediatrics|March 4, 2003
Atopic dermatitis and asthma: parallels in the evolution of treatmentLawrence F Eichenfield, Jon M Hanifin, Lisa A Beck, et al.
Journal of the American Academy of Dermatology|July 16, 2005
Efficacy and safety of tacrolimus ointment treatment for up to 4 years in patients with atopic dermatitisJon M Hanifin, Amy S Paller, Lawrence Eichenfield, et al.
Transplantation|May 8, 2013
Antiviral immune response after live yellow fever vaccination of a kidney transplant recipient treated with IVIGMark K Slifka, Erika Hammarlund, Matthew W Lewis, et al.
Journal of the American Academy of Dermatology|January 17, 2015
A systematic review of topical corticosteroid withdrawal ("steroid addiction") in patients with atopic dermatitis and other dermatosesTamar Hajar, Yael A Leshem, Jon M Hanifin, et al.
Experimental Dermatology|October 18, 2018
The role of phosphodiesterase 4 in the pathophysiology of atopic dermatitis and the perspective for its inhibitionEmma Guttman-Yassky, Jon M Hanifin, Mark Boguniewicz, et al.
Nature Medicine|August 20, 2003
Duration of antiviral immunity after smallpox vaccinationErika Hammarlund, Matthew W Lewis, Scott G Hansen, et al.
The New England Journal of Medicine|March 2, 2017
Anti-Interleukin-31 Receptor A Antibody for Atopic DermatitisThomas Ruzicka, Jon M Hanifin, Masutaka Furue, et al.
Regulatory Toxicology and Pharmacology : RTP|May 3, 2003
The safety assessment of fragrance materialsDavid R Bickers, Peter Calow, Helmut A Greim, et al.
Pageof 8

Showing results (41-50 of 80) with videos related to

Sort By:
Pageof 8
The Journal of Allergy and Clinical Immunology|May 13, 2018
Nemolizumab in patients with moderate-to-severe atopic dermatitis: Randomized, phase II, long-term extension studyKenji Kabashima, Masutaka Furue, Jon M Hanifin, et al.
Dermatology Online Journal|September 7, 2004
Tacrolimus ointment: utilization patterns in children under age 2 yearsTamara Salam Housman, Amy B Norton, Steven R Feldman, et al.
Pediatrics|March 4, 2003
Atopic dermatitis and asthma: parallels in the evolution of treatmentLawrence F Eichenfield, Jon M Hanifin, Lisa A Beck, et al.
Journal of the American Academy of Dermatology|July 16, 2005
Efficacy and safety of tacrolimus ointment treatment for up to 4 years in patients with atopic dermatitisJon M Hanifin, Amy S Paller, Lawrence Eichenfield, et al.
Transplantation|May 8, 2013
Antiviral immune response after live yellow fever vaccination of a kidney transplant recipient treated with IVIGMark K Slifka, Erika Hammarlund, Matthew W Lewis, et al.
Journal of the American Academy of Dermatology|January 17, 2015
A systematic review of topical corticosteroid withdrawal ("steroid addiction") in patients with atopic dermatitis and other dermatosesTamar Hajar, Yael A Leshem, Jon M Hanifin, et al.
Experimental Dermatology|October 18, 2018
The role of phosphodiesterase 4 in the pathophysiology of atopic dermatitis and the perspective for its inhibitionEmma Guttman-Yassky, Jon M Hanifin, Mark Boguniewicz, et al.
Nature Medicine|August 20, 2003
Duration of antiviral immunity after smallpox vaccinationErika Hammarlund, Matthew W Lewis, Scott G Hansen, et al.
The New England Journal of Medicine|March 2, 2017
Anti-Interleukin-31 Receptor A Antibody for Atopic DermatitisThomas Ruzicka, Jon M Hanifin, Masutaka Furue, et al.
Regulatory Toxicology and Pharmacology : RTP|May 3, 2003
The safety assessment of fragrance materialsDavid R Bickers, Peter Calow, Helmut A Greim, et al.
Pageof 8